4
Changes in Ownership
Altimmune, Inc. Filed Acc 0000899243-17-012357
See Remarks acquired 17,787 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Enright William See Remarks | 2017-05-04 | Grant or award | +17,787 | 17,787 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Enright William See Remarks | 2017-05-04 | Grant or award · Stock Options (option to buy) | +125,887 | 125,887 | D: show line 2 in the form | ||
| Enright William See Remarks | 2017-05-04 | Grant or award · Stock Options (option to buy) | +71,644 | 71,644 | D: show line 3 in the form | ||
| Enright William See Remarks | 2017-05-04 | Grant or award · Stock Options (option to buy) | +91,733 | 91,733 | D: show line 4 in the form | ||
| Enright William See Remarks | 2017-05-04 | Grant or award · Stock Options (option to buy) | +183,347 | 183,347 | D: show line 5 in the form | ||
| Enright William See Remarks | 2017-05-04 | Grant or award · Stock Options (option to buy) | +99,927 | 99,927 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…